Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
42 Results Found
ASPR to test automated sterile saline system to help prevent IV shortages
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response June 5 announced it selected two locations to test an automated, point-of-care, sterile saline manufacturing system that could help prevent or mitigate intravenous fluid shortages in the U.S.
Vetted Domestic PPE Manufacturers
Supply chain teams across the U.S. continue to face supply shortages.
Two federal courts block tariffs imposed under emergency law
The U.S. Court of International Trade May 28 blocked (https://www.cit.uscourts.gov/sites/cit/files/25-66.pdf) a series of tariffs issued by the Trump administration under the International Emergency Economic Powers Act, a law granting the president authority to regulate various economic transactions following the declaration of a national emergency.
Tariff Implications for American Health Care
A series of tariffs recently implemented could have significant implications for health care.
Chair File: Leadership Dialogue — Tariffs and Health Care with Brian Pomper and Akin Demehin
In this Leadership Dialogue, I am joined by Brian Pomper, a partner specializing in international trade policy at Akin Gump Strauss Hauer & Feld, and Akin Demehin, vice president of quality and safety policy at the AHA. We discuss tariffs and their potential implications on the health care supply chain.
AHA urges Department of Commerce to enact tariff exceptions for critical minerals used in medical devices
The AHA May 16 urged the Department of Commerce to consid
AHA urges Senate Finance Committee to strengthen supply chain
The AHA May 14 urged the Senate Finance Committee to take steps to strengthen the supply chain for essential pharmaceutical and other medical products.
U.S., China temporarily agree to reduce tariffs for 90 days
The U.S. and China reached a joint agreement to temporarily reduce tariffs for 90 days, the White House announced May 12. Both countries will lower tariffs by 115% effective May 14.
AHA comments on national security investigation of pharmaceutical imports
AHA May 6 submitted comments to the Department of Commerce on its Section 232 national security investigation of pharmaceutical and pharmaceutical ingredients imports.
Trump announces reciprocal tariffs paused for 90 days
President Trump April 9 announced that reciprocal tariffs that went into effect after midnight for certain nations will be paused for 90 days, while tariffs for China would be increased to 125%.